Products cover hundreds of varieties such as antibiotics, digestive system, cardiovascular and cerebrovascular diseases, antipyretic and analgesic drugs and vitamins. Including freeze-dried powder for injection, powder for injection, capsules, tablets and granules. The main products are penicillin sodium, ampicillin sodium, cefazolin sodium, cefradine, ceftriaxone sodium, cefotaxime sodium, cefoperazone sodium, amoxicillin capsules, amoxicillin dispersible tablets, amoxicillin granules and Guoweikang. At the same time, Zhongnuo Pharmaceutical has a strong preparation production capacity, with an annual output of 65.438+0.8 billion needles, 4.6 billion capsules and 3.6 billion tablets. Zhongnuo Pharmaceutical is the most important preparation processing and production base in China.
Zhongnuo Pharmaceutical always puts product quality first in enterprise development, establishes a strict three-level quality management system and fully implements GMP standards. In addition to CP, BP, USP and other advanced testing standards at home and abroad, the company has also formulated internal standards higher than the above standards to double check the quality. More than 300 high-quality quality inspectors are responsible for the quality control of the whole production process, and more than 50 internationally advanced testing equipment provide strong quality assurance for product inspection. In addition, Zhongnuo Pharmaceutical also invested hundreds of millions of yuan in GMP transformation. Up to now, all the production workshops have passed GMP certification and obtained GMP certificate 10, including 10 raw materials and 15 dosage forms. It is one of the earliest enterprises in China to implement GMP certification. While strictly implementing GMP quality standards, the company launched COS and MCC international quality certification for the international market, which accelerated the pace of product internationalization. In addition, the company does not forget to care about the health, safety and environmental protection of employees, and has passed the three system certifications of ISO900 1, ISO 1400 1 and OHSAS 18000 respectively, and established a perfect quality assurance system.
Generic drugs need service and quality, as well as continuous innovation and product upgrading to keep up with the latest development of human health needs. Relying on the strong R&D advantages of Unacon postdoctoral workstation, Zhongnuo Pharmaceutical has established a three-level R&D organization, which specializes in the imitation and research and development of generic drugs, and established a high-quality R&D team of more than 200 people in the company and workshop to tackle scientific research problems. Every year, there are more than a dozen new products on the market. A large number of new products, such as Sino-Novo Collin, Sino-Novo Gio, Sino-Novo Jialin, Sino-Novo Paishu, Guowei Kang Xin and so on, have been put on the market and become a new force to promote the development of enterprises.
Zhongnuo Pharmaceutical has a sales system of generic drugs, new drugs, APIs, foreign trade, OTC and health products. It has set up more than 60 offices and a sales team of more than 65,438+0,000 people all over the country to provide first-class professional services to customers. In addition, Sino-Norwegian Pharmaceutical has established stable economic, technical and information cooperation relations with more than 20 countries and regions such as Germany, Japan, Spain, Netherlands, Switzerland, Denmark and Italy. With strong enterprise strength, Zhongnuo Pharmaceutical has won wide recognition in the market. Shi Yao's main trademark was recognized as a well-known trademark in China by the State Administration for Industry and Commerce, and brands such as Shi Yao, Amoxicillin Capsule and Ceftriaxone Sodium were awarded the title of famous brand products in China. In June 2006, Shoutang and Zhongnuo were recognized as "Famous Trademarks of Hebei Province" by Hebei Administration for Industry and Commerce.
As a mainland Hong Kong-funded enterprise, Sino Pharmaceutical shoulders the consent of all Hong Kong shareholders of Unacon and China Pharmaceutical, and makes a solemn commitment to the cause of human health based on China and facing the world. Facing the surging global pharmaceutical economy and the surging wave of pharmaceutical development in China, China Pharmaceutical has determined the "two most" development strategies, namely, building the most professional antibiotic powder injection production base in China and the most important generic drug supplier in China.
Contact: Dong Qingjie
Venue: Gongnong Road 188, Shijiazhuang, Hebei Province
Postal code: 05005 1